Pengtao Zou - Publications

AHSA1/Hsp90α Complex Facilitates Microglial Mitophagy by Targeting TOMM70 in Parkinson Disease.

Journal: The American journal of pathology

Published: December 03, 2024

Artesunate Inhibits Myocardial Ischemia Reperfusion Injury via Downregulation of Lysine Specific Demethylase 5A.

Journal: Chemical biology & drug design

Published: November 07, 2024

Circ-0006332 stimulates cardiomyocyte pyroptosis via the miR-143/TLR2 axis to promote doxorubicin-induced cardiac damage.

Journal: Epigenetics

Published: July 17, 2024

The protective effect of Ghrelin peptide on doxorubicin hydrochloride induced heart failure in rats.

Journal: Journal of cardiothoracic surgery

Published: April 17, 2024

Effect of aortic smooth muscle BK channels on mediating chronic intermittent hypoxia-induced vascular dysfunction.

Journal: The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology

Published: November 23, 2023

TLR2 activates AP-1 to facilitate CTGF transcription and stimulate doxorubicin-induced myocardial injury.

Journal: British journal of pharmacology

Published: July 28, 2023

RNA methylation reading protein YTHDF2 relieves myocardial ischemia-reperfusion injury by downregulating BNIP3 via m6A modification.

Journal: Human cell

Published: May 06, 2023

NOX4 aggravates doxorubicin-induced cardiomyocyte pyroptosis by increasing reactive oxygen species content and activating the NLRP3 inflammasome.

Journal: Cardiovascular diagnosis and therapy

Published: March 30, 2023

Bone marrow stromal cell-derived exosomes improve oxidative stress and pyroptosis in doxorubicin-induced myocardial injury in vitro by regulating the transcription of GSDMD through the PI3K-AKT-Foxo1 pathway.

Journal: Immunity, inflammation and disease

Published: November 08, 2022

Development and Validation of a Novel Prognostic Model Predicting the Atrial Fibrillation Recurrence Risk for Persistent Atrial Fibrillation Patients Treated with Nifekalant During the First Radiofrequency Catheter Ablation.

Journal: Cardiovascular drugs and therapy

Published: June 06, 2022

SIRT4 Suppresses Doxorubicin-Induced Cardiotoxicity by Regulating the AKT/mTOR/Autophagy Pathway.

Journal: Toxicology

Published: October 07, 2021

CBL aggravates Ang II-induced cardiac hypertrophy via the VHL/HIF-1α pathway.

Journal: Experimental cell research

Published: April 15, 2021